COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
about
Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancerMeta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.Association between COX-2 -1195G>A polymorphism and gastrointestinal cancer risk: A meta-analysis.Pharmacogenomics of cyclooxygenases.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk.Effects of celecoxib on cell apoptosis and Fas, FasL and Bcl-2 expression in a BGC-823 human gastric cancer cell line.Cyclooxygenase-2 -1195G>A (rs689466) polymorphism and cancer susceptibility: an updated meta-analysis involving 50,672 subjects.The triune of intestinal microbiome, genetics and inflammatory status and its impact on the healing of lower gastrointestinal anastomoses.Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.Enhanced cyclooxygenase-2 activity leads to intestinal dysmotility following hemorrhagic shock.Effects of gene polymorphisms of metabolic enzymes on the association between red and processed meat consumption and the development of colon cancer; a literature reviewAssociation between cyclooxygenase-2 (COX-2) 8473 T > C polymorphism and cancer risk: a meta-analysis and trial sequential analysis
P2860
Q34477434-ECACA605-AC8B-46D5-844F-FB89B4A0C816Q35147941-9B00852A-6E6B-485F-BA8D-D4C1B1BD2DF3Q35246178-4B961689-F002-4580-B3D7-079E3241994BQ37659105-65F97FD8-1367-4A4D-A7EF-649614A6DD09Q37730897-F88F8DC7-6C1B-41A0-9BA9-679C387DACB2Q38444433-B8F232E9-A89A-45EA-9A26-76D90A849338Q38557891-F9E4378F-D735-46AC-AB50-E951E34557CBQ39005259-F3174988-3C50-45B1-B24F-329DB08F572EQ41672403-455E6C50-AB8F-4293-80E9-1F01B489CFA7Q43210244-5DF112AD-6716-4FB4-990F-7E892664AE00Q47563895-F7C9565D-2C9E-4920-AD0C-2CE41BBABE50Q48503138-242A294C-F4AD-4307-886A-52477D6850FEQ52666811-0555D980-688E-4016-8631-FB089D6847D0Q57298291-DACD43C7-1CBC-4D2F-B79A-B1EEB1E48ED8Q58707390-969A44D5-26D1-4A89-953C-2A05ED9E6E58
P2860
COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
COX-1 (PTGS1) and COX-2 (PTGS2 ...... n two independent populations.
@en
COX-1 (PTGS1) and COX-2 (PTGS2 ...... n two independent populations.
@nl
type
label
COX-1 (PTGS1) and COX-2 (PTGS2 ...... n two independent populations.
@en
COX-1 (PTGS1) and COX-2 (PTGS2 ...... n two independent populations.
@nl
prefLabel
COX-1 (PTGS1) and COX-2 (PTGS2 ...... n two independent populations.
@en
COX-1 (PTGS1) and COX-2 (PTGS2 ...... n two independent populations.
@nl
P2093
P2860
P50
P1476
COX-1 (PTGS1) and COX-2 (PTGS2 ...... n two independent populations.
@en
P2093
Alexa J Resler
Brenna Seufert
Christine F Rimorin
Christopher S Carlson
Cornelia M Ulrich
David Duggan
John A Baron
John Whitton
Karen Curtin
Karen W Makar
P2860
P2888
P304
P356
10.1007/S10552-013-0282-1
P577
2013-12-01T00:00:00Z